Cargando…

Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis

Detalles Bibliográficos
Autor principal: Sun, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690562/
https://www.ncbi.nlm.nih.gov/pubmed/29152613
_version_ 1783279629686013952
author Sun, Jun
author_facet Sun, Jun
author_sort Sun, Jun
collection PubMed
description
format Online
Article
Text
id pubmed-5690562
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-56905622017-11-16 Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis Sun, Jun J Neurol Neuromedicine Article 2017-06-12 2017 /pmc/articles/PMC5690562/ /pubmed/29152613 Text en http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 International License
spellingShingle Article
Sun, Jun
Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
title Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
title_full Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
title_fullStr Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
title_full_unstemmed Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
title_short Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis
title_sort commentary: target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690562/
https://www.ncbi.nlm.nih.gov/pubmed/29152613
work_keys_str_mv AT sunjun commentarytargetintestinalmicrobiotatoalleviatediseaseprogressioninamyotrophiclateralsclerosis